ROTEC

ROTEC commercializes a university-originated process called Flow Reversal Reverse Osmosis (FR-RO) that periodically reverses the flow direction and rotates membrane blocks inside conventional RO pressure vessels. The practical effect is to prevent nascent mineral scale and biofilm from adhering to membrane surfaces, which in conventional high-recovery RO forces frequent chemical cleanings or limits recovery rates. ROTEC’s product set includes both new-build high-recovery FR-RO trains and retrofit packages that let operators convert existing RO plants to the FR-RO process with modest capital outlay and full fallback to conventional RO operation.

The core technology is an operational control and valve/actuator topology combined with staged membrane-block rotation and automated sequencing. No specialized membranes are required; the system uses standard membrane elements but adds control logic, valve manifolds and instrumentation to time reversals based on induction-time principles. That enables utilities to run systems at 90–95% recovery (or higher in favorable feedwater) while maintaining membrane life and avoiding the economic and environmental costs of large brine volumes. ROTEC’s technical literature and trade coverage emphasize reduced chemical consumption, fewer CIP events, higher permeate yield per feed, and retrofit compatibility as principal differentiators.

On customers and traction: ROTEC’s technology has been piloted and deployed in multiple international testbeds and retrofit projects. Public reporting and interviews cite early pilots with Israel’s utility Mekorot and retrofit work in Singapore (the Kranji Water Reclamation Plant), plus commercial partnerships and representation through regional integrators such as Smart Water Group in the United States. Industry writeups document demonstrable gains (typical recovery improvements of ~15–20% in field pilots) and recognition on the trade circuit (including a Rising Star award at TechXchange / SIWW). The firm’s narrative is one of academic proof-of-concept (Ben-Gurion University research) transitioned into an applied retrofit solution with real-world operational case studies rather than a purely lab-stage novelty.

Competitive dynamics: ROTEC competes indirectly with large desalination and membrane incumbents (IDE, SUEZ, Veolia) and membrane manufacturers (Toray, Hydranautics), but its go-to-market is different: lower‑cost retrofit upgrades and targeted new-build high-recovery trains rather than wholesale plant replacement. That positioning reduces capital barriers for adoption in municipal and industrial plants that prefer incremental upgrades. The technology’s strength is process-level IP and operating methodology (timing, rotation, control logic) rather than a new membrane chemistry; this eases integration but invites competing operational workarounds by established players, so monitoring adoption and licensing arrangements is an important diligence axis.

Strategic and resilience relevance: FR-RO directly improves water security metrics—more potable output per unit feed, smaller brine waste volumes, and an architecture that is amenable to distributed, inland, or expeditionary deployments (where brine disposal options are constrained). For defense and critical-infrastructure applications FR-RO is materially relevant: military bases, naval logistics hubs, and emergency/disaster-water installations all benefit from higher recovery and lower resupply needs. Recent trade reporting also highlights FR-RO’s applicability to PFAS mitigation planning because higher-recovery RO can concentrate PFAS into a much smaller waste stream that is easier to manage and treat, which increases the technology’s relevance to regulated drinking-water resilience.

Open diligence questions remain: the company’s scale economics vs incumbents for very large SWRO mega-plants (100s of MLD), the durability of control hardware under harsh field regimes, the commercial terms for retrofits (CAPEX/ASP, licensing, recurring service revenue), and the degree to which larger engineering firms can replicate the process in-house or if ROTEC retains defendable commercial moats. Public sources document pilots and awards but not a large, well-documented pipeline of multi-hundred‑MLD plants; validating commercial contracts, full-year revenue run rates, and any export control or defense contracting relationships would be next-step checks for an investor or strategic acquirer doing deeper diligence.